Takuya Kishi Selected Research

Takuya Kishi Research Topics

Disease

38	Heart Failure 04/2024 - 12/2003
33	Hypertension (High Blood Pressure) 01/2023 - 01/2003
23	Stroke (Strokes) 10/2023 - 02/2002
12	Myocardial Infarction 10/2023 - 02/2006
6	Body Weight (Weight, Body) 03/2024 - 12/2007
6	COVID-19 10/2022 - 10/2020
5	Hemorrhage 02/2024 - 02/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2008
5	Left Ventricular Dysfunction 01/2016 - 02/2006
4	Diabetes Mellitus 03/2024 - 12/2003
4	Infarction (Infarctions) 01/2018 - 01/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 04/2023 - 02/2006
3	Bradycardia 01/2019 - 01/2003
3	Ischemia 01/2019 - 01/2017
3	Inflammation (Inflammations) 01/2018 - 01/2012
3	Obesity 01/2015 - 01/2011
3	Cognitive Dysfunction 01/2015 - 01/2012
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2024 - 02/2014
2	Chronic Renal Insufficiency 10/2023 - 12/2019
2	Infections 04/2023 - 10/2020
2	Thromboembolism 01/2022 - 11/2008
2	Pulmonary Hypertension 01/2020 - 01/2011
2	Hypotension (Low Blood Pressure) 01/2019 - 01/2003
2	Pulmonary Arterial Hypertension 01/2019 - 10/2018
2	AIDS-Related Complex (ARC) 01/2019 - 09/2014
2	Ventricular Remodeling 01/2013 - 05/2007
1	Bone Fractures (Bone Fracture) 05/2024
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2024
1	Peripheral Arterial Disease 10/2023
1	Neoplasms (Cancer) 04/2023
1	Hyperaldosteronism (Conn Syndrome) 01/2023
1	Encephalitis (Encephalitis, Rasmussen) 01/2023
1	Cardiomegaly (Heart Hypertrophy) 04/2022
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Death (Near-Death Experience) 01/2022

Drug/Important Bio-Agent (IBA)

9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 01/2003
9	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2014 - 05/2004
8	AntioxidantsIBA 02/2018 - 12/2008
8	Type 1 Angiotensin ReceptorIBA 01/2016 - 12/2009
7	Atorvastatin (Lipitor)FDA Link 01/2012 - 02/2003
5	Indicators and Reagents (Reagents)IBA 01/2023 - 12/2007
5	Angiotensin IIIBA 01/2017 - 02/2010
5	Hydralazine (Apresoline)FDA LinkGeneric 04/2015 - 12/2008
4	SaltsIBA 01/2023 - 11/2008
4	Oxygen (Dioxygen)IBA 01/2019 - 01/2016
4	Telmisartan (Micardis)FDA Link 02/2014 - 09/2012
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2022 - 12/2012
3	salicylhydroxamic acid (SHAM)IBA 04/2022 - 01/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 06/2007
3	Angiotensin Receptor AntagonistsIBA 10/2020 - 01/2012
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 01/2013
3	NADP (NADPH)IBA 01/2012 - 07/2007
3	Superoxide DismutaseIBA 01/2012 - 12/2008
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2008 - 12/2003
3	rho-Associated KinasesIBA 05/2005 - 06/2003
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2003 - 02/2002
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2024 - 01/2022
2	dapagliflozinIBA 10/2023 - 01/2023
2	C-Reactive ProteinIBA 01/2022 - 12/2007
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Antihypertensive Agents (Antihypertensives)IBA 10/2020 - 01/2019
2	CytokinesIBA 01/2017 - 01/2012
2	Losartan (Cozaar)FDA LinkGeneric 04/2015 - 10/2012
2	Insulin (Novolin)FDA Link 01/2015 - 10/2012
2	TropomyosinIBA 01/2015 - 12/2012
2	Phosphotransferases (Kinase)IBA 01/2015 - 12/2012
2	Blood Glucose (Blood Sugar)IBA 01/2015 - 10/2012
2	AdiponectinIBA 01/2015 - 10/2012
2	Toll-Like Receptor 4IBA 01/2013 - 11/2011
2	candesartanIBA 09/2012 - 01/2012
2	olmesartanIBA 01/2012 - 12/2009
2	azelnidipineIBA 01/2012 - 12/2008
2	Amlodipine (Norvasc)FDA LinkGeneric 01/2012 - 01/2012
2	Oxidoreductases (Dehydrogenase)IBA 12/2008 - 07/2007
2	Superoxides (Superoxide)IBA 05/2004 - 12/2003
1	Alkaline PhosphataseIBA 05/2024
1	Serum AlbuminIBA 05/2024
1	Peptide Hydrolases (Proteases)FDA Link 03/2024
1	Triglycerides (Triacylglycerol)IBA 03/2024
1	Proton Pump InhibitorsIBA 02/2024
1	Uric Acid (Urate)IBA 01/2024
1	AldosteroneIBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	CholesterolIBA 01/2022
1	AlbuminsIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022

Therapy/Procedure

14	Therapeutics 10/2023 - 02/2006
6	Vagus Nerve Stimulation 10/2018 - 09/2014
5	Renal Dialysis (Hemodialysis) 05/2024 - 01/2022
4	Oral Administration 04/2015 - 11/2009
3	Denervation 04/2024 - 04/2015
3	Percutaneous Coronary Intervention 05/2007 - 02/2006
2	Patient Readmission 10/2023 - 01/2023
2	Cardiac Rehabilitation 10/2022 - 05/2021
2	Extracorporeal Membrane Oxygenation 01/2021 - 04/2015
2	Sympathectomy (Sympathectomies) 11/2016 - 04/2015
1	Drug Therapy (Chemotherapy) 03/2024
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Palliative Care (Palliative Therapy) 01/2022